Haemonetics Corp (HAE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 346,351 | 338,967 | 327,315 | 321,394 | 330,599 |
| Cost of Goods | 148,139 | 136,581 | 132,571 | 129,150 | 137,549 |
| Gross Profit | 198,212 | 202,386 | 194,744 | 192,244 | 193,050 |
| Operating Expenses | 221,376 | 135,571 | 136,824 | 138,522 | 122,264 |
| Operating Income | -23,025 | 67,396 | 58,491 | 53,872 | 71,335 |
| Interest Expense | 5,374 | 7,421 | 7,206 | 8,703 | 598 |
| Pre-tax Income | -28,399 | 59,975 | 51,285 | 45,169 | 70,737 |
| Income Tax | -8,252 | 15,235 | 12,601 | 11,138 | 12,756 |
| Net Income Continuous | -20,147 | 44,740 | 38,684 | 34,031 | 57,981 |
| Net Income | $-20,147 | $44,740 | $38,684 | $34,031 | $57,981 |
| EPS Basic Total Ops | -0.42 | 0.96 | 0.81 | 0.71 | 1.17 |
| EPS Basic Continuous Ops | -0.41 | 0.96 | 0.81 | 0.71 | 1.17 |
| EPS Diluted Total Ops | -0.41 | 0.95 | 0.81 | 0.70 | 1.17 |
| EPS Diluted Continuous Ops | -0.41 | 0.95 | 0.81 | 0.70 | 1.16 |
| EPS Diluted Before Non-Recurring Items | 1.29 | 1.31 | 1.27 | 1.10 | 1.24 |
| EBITDA(a) | $4,294 | $96,104 | $88,801 | $85,066 | $102,180 |